Taiwan FDA registration 41fbce907fc2538a50e7116ee50cbe3e
"IF" Follicular Stimulating Hormone (FSH) Rapid Test (Non-Sterile)
TW: “依芙”卵泡刺激激素檢測試劑 (未滅菌)
Taiwan·Risk Class 1·MD·FIRSTEP BIORESEARCH INC.·Registered Oct 31, 2018 – Oct 31, 2023ExpiredRegistration details
- Analysis ID
- 41fbce907fc2538a50e7116ee50cbe3e
- License Form
- Ministry of Health Medical Device Manufacturing No. 007508
Company information
- Manufacturer
- FIRSTEP BIORESEARCH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- FIRSTEP BIORESEARCH INC.
Product details
- Intended Use
- Limited to the first level recognition range of the follicle-stimulating hormone test system (A.1300) of the management method of medical equipment.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1300 Follicle-stimulating hormone testing system
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Oct 31, 2018
- Expiry Date
- Oct 31, 2023
About this record
Access comprehensive regulatory information for "IF" Follicular Stimulating Hormone (FSH) Rapid Test (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 41fbce907fc2538a50e7116ee50cbe3e and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices